tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

OPHLF Stock Latest News

ONO Pharmaceutical Reports Strong Q2 Financial Performance with Revenue Growth
Company AnnouncementsONO Pharmaceutical Reports Strong Q2 Financial Performance with Revenue Growth
2M ago
Ono Pharmaceutical’s Tirabrutinib Study: Key Insights for Investors
PremiumCompany Announcements
Ono Pharmaceutical’s Tirabrutinib Study: Key Insights for Investors
2M ago
OPHLF
Ono Pharmaceutical’s Phase 3 Trial: A New Hope for PCNSL Treatment
PremiumCompany Announcements
Ono Pharmaceutical’s Phase 3 Trial: A New Hope for PCNSL Treatment
2M ago
OPHLF
Ono Pharmaceutical’s ONO-1110: A Promising Study for Interstitial Cystitis
PremiumCompany Announcements
Ono Pharmaceutical’s ONO-1110: A Promising Study for Interstitial Cystitis
2M ago
OPHLF
ONO Pharmaceutical Advances Fibromyalgia Treatment with ONO-1110 Study
PremiumCompany Announcements
ONO Pharmaceutical Advances Fibromyalgia Treatment with ONO-1110 Study
2M ago
OPHLF
Ono Pharmaceutical’s ONO-4538 Study: A Potential Game-Changer for Richter’s Transformation
PremiumCompany AnnouncementsOno Pharmaceutical’s ONO-4538 Study: A Potential Game-Changer for Richter’s Transformation
2M ago
OPHLF
Bristol-Myers Squibb and ONO Pharmaceutical’s New Study on Nivolumab for NSCLC: What Investors Need to Know
Premium
Company Announcements
Bristol-Myers Squibb and ONO Pharmaceutical’s New Study on Nivolumab for NSCLC: What Investors Need to Know
2M ago
BMY
ONO Pharmaceutical’s BRILLIANT Study: A Potential Breakthrough for Steroid-resistant Pemphigus
Premium
Company Announcements
ONO Pharmaceutical’s BRILLIANT Study: A Potential Breakthrough for Steroid-resistant Pemphigus
2M ago
OPHLF
Ono Pharmaceutical’s ONO-1110: A Promising Treatment for Postherpetic Neuralgia
PremiumCompany Announcements
Ono Pharmaceutical’s ONO-1110: A Promising Treatment for Postherpetic Neuralgia
2M ago
OPHLF
ONO Pharmaceutical’s ONO-2020: A Promising Alzheimer’s Study Update
PremiumCompany Announcements
ONO Pharmaceutical’s ONO-2020: A Promising Alzheimer’s Study Update
2M ago
OPHLF
ONO Pharmaceutical’s Phase III Study on Cenobamate: A Potential Game-Changer for Epilepsy Treatment
PremiumCompany Announcements
ONO Pharmaceutical’s Phase III Study on Cenobamate: A Potential Game-Changer for Epilepsy Treatment
2M ago
OPHLF
Ono Pharmaceutical’s ONO-4538 Study: A Closer Look at Its Market Potential
PremiumCompany Announcements
Ono Pharmaceutical’s ONO-4538 Study: A Closer Look at Its Market Potential
2M ago
OPHLF
ONO Pharmaceutical’s ONO-2020: A Promising Study in Alzheimer’s Agitation
PremiumCompany AnnouncementsONO Pharmaceutical’s ONO-2020: A Promising Study in Alzheimer’s Agitation
2M ago
OPHLF
Ono Pharmaceutical’s Cenobamate Study: A Potential Game-Changer for Epilepsy Treatment
Premium
Company Announcements
Ono Pharmaceutical’s Cenobamate Study: A Potential Game-Changer for Epilepsy Treatment
2M ago
OPHLF
ONO Pharmaceutical’s ONO-1110 Trial: A Potential Game-Changer for Major Depressive Disorder
Premium
Company Announcements
ONO Pharmaceutical’s ONO-1110 Trial: A Potential Game-Changer for Major Depressive Disorder
2M ago
OPHLF
Ono Pharmaceutical’s ONO-4538: A Promising Study in Rhabdoid Tumor Treatment
PremiumCompany Announcements
Ono Pharmaceutical’s ONO-4538: A Promising Study in Rhabdoid Tumor Treatment
2M ago
OPHLF
ONO Pharmaceutical’s ONO-4685: A Promising Phase I Study in T Cell Lymphoma and CLL/SLL
PremiumCompany Announcements
ONO Pharmaceutical’s ONO-4685: A Promising Phase I Study in T Cell Lymphoma and CLL/SLL
2M ago
OPHLF
Ono Pharmaceutical’s ONO-1110: A Promising Study for Social Anxiety Disorder
PremiumCompany Announcements
Ono Pharmaceutical’s ONO-1110: A Promising Study for Social Anxiety Disorder
2M ago
OPHLF
ONO Pharmaceutical’s ONO-7428 Study: A New Hope for Solid Tumor Treatment
PremiumCompany Announcements
ONO Pharmaceutical’s ONO-7428 Study: A New Hope for Solid Tumor Treatment
2M ago
OPHLF
Ono Pharmaceutical’s ONO-4685 Study: A Potential Game Changer in T Cell Lymphoma Treatment
PremiumCompany AnnouncementsOno Pharmaceutical’s ONO-4685 Study: A Potential Game Changer in T Cell Lymphoma Treatment
2M ago
OPHLF
Ono Pharmaceutical’s New Phase 2 Study: A Potential Game-Changer in Colorectal Cancer Treatment
Premium
Company Announcements
Ono Pharmaceutical’s New Phase 2 Study: A Potential Game-Changer in Colorectal Cancer Treatment
2M ago
OPHLF
Ono Pharmaceutical’s New Study on Tirabrutinib: What Investors Need to Know
Premium
Company Announcements
Ono Pharmaceutical’s New Study on Tirabrutinib: What Investors Need to Know
2M ago
OPHLF

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >